Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Stanford University
Stanford University
Pfizer
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Columbia University
INSYS Therapeutics Inc